Benjamin J. Zeskind's Insider Trades & SAST Disclosures
Benjamin J. Zeskind's most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 480,000 Stock Option done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Benjamin J. Zeskind.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 480,000 | 480,000 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.77 per share. | 19 Mar 2024 | 20,000 | 2,281,852 | - | 2.8 | 55,326 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Zeskind Benjamin J. | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 244,286 | 244,286 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Zeskind Benjamin J. | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 16,414 | 16,414 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 352,244 | 352,244 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 21,756 | 374,000 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2022 | 2,500 | 203,500 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.01 per share. | 22 Dec 2022 | 2,500 | 2,261,852 | - | 3.0 | 7,525 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.01 per share. | 12 Apr 2022 | 2,000 | 2,259,352 | - | 3.0 | 6,020 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 2,000 | 206,000 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.02 per share. | 23 Mar 2022 | 3,000 | 2,257,352 | - | 8.0 | 24,060 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 2,000 | 208,000 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.01 per share. | 28 Feb 2022 | 2,000 | 2,254,352 | - | 3.0 | 6,020 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 156,485 | 156,485 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 45,615 | 202,100 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 22.87 per share. | 13 Sep 2021 | 2,083 | 2,602,352 | - | 22.9 | 47,632 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, President and CEO, Ten Percent Owner | 03 Aug 2021 | 49,099 | 2,598,171 | - | - | Class A Common Stock | ||
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, President and CEO, Ten Percent Owner | 03 Aug 2021 | 40,928 | 0 | - | - | Series A Preferred Stock | ||
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, President and CEO, Ten Percent Owner | 03 Aug 2021 | 8,171 | 0 | - | - | Series B Preferred Stock | ||
| Immuneering Corp - Ordinar... | Benjamin J. Zeskind | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Aug 2021 | 2,098 | 2,600,269 | - | 15 | 31,470 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges